What is the long-term trend for Nektar Therapeutics's software and technology licenses, net?

Over 5 years (2020 to 2025), Nektar Therapeutics's software and technology licenses, net has grown at a 57.5% compound annual growth rate (CAGR), from $1.46M to $14.14M.

Nektar Therapeutics NKTR Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

AmgenAMGN

——

Regeneron PharmaceuticalsREGN

——

Apogee Therapeutics, Inc.APGE

——

ImmunomeIMNM

——

Vera TherapeuticsVERA

——

Iovance Biotherapeutics, Inc.IOVA

——

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's software and technology licenses, net?: Nektar Therapeutics (NKTR) reported software and technology licenses, net of $11.24M in Q1 2026.
How has Nektar Therapeutics's software and technology licenses, net changed year-over-year?: Nektar Therapeutics's software and technology licenses, net increased by 108.4% year-over-year, from $5.39M to $11.24M.
What is the long-term trend for Nektar Therapeutics's software and technology licenses, net?: Over 5 years (2020 to 2025), Nektar Therapeutics's software and technology licenses, net has grown at a 57.5% compound annual growth rate (CAGR), from $1.46M to $14.14M.